Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
O'Shaughnessy, J.
Obesity, breast cancer risk and Insulin-Like Growth Factor Receptor Pathway Targets Intracellular Signaling Kinases (E.g., Src, P13k/Akt/Mtor; Mapk; Sonic Hedgehog Pathways)
Oblimersen (Genasense) Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Targeting Apoptosis
Oblimersen sodium Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Targeting Apoptosis
Ocular toxicities EGFRI combined with radiation therapy, 88-89 eyelid changes, 88 tear film changes Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) References (Chapter 2)
Olaparib (AZD2281), PARP1 inhibitors and
Omnitarg,
Oncogenes
Oncology Nursing Society Encouraging Patient Adherence and Persistence References (Chapter 2)
ONJ,
Oral anticancer therapy adherence to and persistence with, 302-303 supporting, successful strategies for Encouraging Patient Adherence and Persistence
Oral tyrosine kinase EGFRIs
OS,
Osteoblasts bone building, breakdown and Bone Metastasis Invasion and Metastasis multiple myeloma and proliferation and differentiation, factors related to
Osteoclastogenesis, RANKL and
Osteoclasts bone building, breakdown and Bone Metastasis formation and activation of Glossary Invasion and Metastasis multiple myeloma and Pharmacologic Management References (Chapter 4) stimulation and regulation of local factors related to, 256 systemic factors related to
Osteolytic lesions, multiple myeloma and Bone Metastasis Pharmacologic Management
Osteonecrosis of the jaw bisphosphonate-related, staging and recommendations for treatment of bisphosphonate therapy and pamidronate and Pharmacologic Management References (Chapter 4) Targeting Apoptosis zoledronic acid and
Osteoporosis Bone Metastasis Pharmacologic Management
Osteoprotegerin Bone Metastasis Pharmacologic Management References (Chapter 4)
Ovarian cancer, EGFR overexpression in Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Monoclonal Antibodies
Overall survival Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Glossary Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Mitotic Kinase Inhibitors
OXiGENE Antiangiogenic Drug Therapy Hypoxia-Inducible Factor, Mtor, and Angiogenesis